BioCentury | Sep 11, 2006
Strategy

Biotech accumulators

...ground for Santhera, which was created in 2004 through the merger of MyoContract AG and Graffinity Pharmaceuticals AG...
BioCentury | Jan 9, 2006
Company News

Santhera Pharmaceuticals AG supply/service news

...will receive undisclosed revenues from the newco. Santhera was formed through the 2004 merger of Graffinity Pharmaceuticals AG...
BioCentury | Jan 9, 2006
Strategy

Working through the checklist

...more focus as well. Santhera (Liestal, Switzerland) was created in 2004 through the merger of Graffinity Pharmaceuticals AG...
BioCentury | Jun 27, 2005
Product Development

Insulin rush

...once-per-day dosing." Santhera Pharmaceuticals AG (Liestal, Switzerland), which was formed through the 2004 merger of Graffinity Pharmaceuticals AG...
BioCentury | Jan 24, 2005
Emerging Company Profile

Mutabilis: Blocking the blood highway

...one of the natural substrates to the undisclosed enzyme it's targeting. Mutabilis then worked with Graffinity Pharmaceuticals AG...
BioCentury | Jan 24, 2005
Emerging Company Profile

Corporate Profile

...Nassif University collaborators: University of Medicine Necker, Ecole Normale Superiore Corporate partners: 4SC AG , Graffinity Pharmaceuticals AG...
BioCentury | Oct 4, 2004
Finance

Europe: The news will be light

...a company-driven deal. Another recently completed company-driven merger was between functional genomics and metabolic company Graffinity Pharmaceuticals AG...
BioCentury | Sep 13, 2004
Company News

Graffinity Pharmaceuticals AG, MyoContract deal

...becomes CEO of Santhera, and Thomas Meier, founder and CEO of MyoContract, is now CSO. Graffinity Pharmaceuticals AG...
BioCentury | Dec 8, 2003
Company News

Graffinity Pharmaceuticals AG management update

Graffinity Pharmaceuticals AG , Heidelberg, Germany Business: Functional genomics Hired: Paul Edwards as associate director of medicinal chemistry, formerly principle scientist at Pfizer Global Research and Development WIR Staff...
BioCentury | Nov 17, 2003
Company News

Graffinity Pharmaceuticals AG management update

Graffinity Pharmaceuticals AG , Heidelberg, Germany Business: Functional genomics Hired: Mathias Woker as VP of business development USA, formerly VP of business development at Spherics Inc. WIR Staff...
Items per page:
1 - 10 of 19
BioCentury | Sep 11, 2006
Strategy

Biotech accumulators

...ground for Santhera, which was created in 2004 through the merger of MyoContract AG and Graffinity Pharmaceuticals AG...
BioCentury | Jan 9, 2006
Company News

Santhera Pharmaceuticals AG supply/service news

...will receive undisclosed revenues from the newco. Santhera was formed through the 2004 merger of Graffinity Pharmaceuticals AG...
BioCentury | Jan 9, 2006
Strategy

Working through the checklist

...more focus as well. Santhera (Liestal, Switzerland) was created in 2004 through the merger of Graffinity Pharmaceuticals AG...
BioCentury | Jun 27, 2005
Product Development

Insulin rush

...once-per-day dosing." Santhera Pharmaceuticals AG (Liestal, Switzerland), which was formed through the 2004 merger of Graffinity Pharmaceuticals AG...
BioCentury | Jan 24, 2005
Emerging Company Profile

Mutabilis: Blocking the blood highway

...one of the natural substrates to the undisclosed enzyme it's targeting. Mutabilis then worked with Graffinity Pharmaceuticals AG...
BioCentury | Jan 24, 2005
Emerging Company Profile

Corporate Profile

...Nassif University collaborators: University of Medicine Necker, Ecole Normale Superiore Corporate partners: 4SC AG , Graffinity Pharmaceuticals AG...
BioCentury | Oct 4, 2004
Finance

Europe: The news will be light

...a company-driven deal. Another recently completed company-driven merger was between functional genomics and metabolic company Graffinity Pharmaceuticals AG...
BioCentury | Sep 13, 2004
Company News

Graffinity Pharmaceuticals AG, MyoContract deal

...becomes CEO of Santhera, and Thomas Meier, founder and CEO of MyoContract, is now CSO. Graffinity Pharmaceuticals AG...
BioCentury | Dec 8, 2003
Company News

Graffinity Pharmaceuticals AG management update

Graffinity Pharmaceuticals AG , Heidelberg, Germany Business: Functional genomics Hired: Paul Edwards as associate director of medicinal chemistry, formerly principle scientist at Pfizer Global Research and Development WIR Staff...
BioCentury | Nov 17, 2003
Company News

Graffinity Pharmaceuticals AG management update

Graffinity Pharmaceuticals AG , Heidelberg, Germany Business: Functional genomics Hired: Mathias Woker as VP of business development USA, formerly VP of business development at Spherics Inc. WIR Staff...
Items per page:
1 - 10 of 19